VENUS CONCEPT INC. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing - Marketscreener.com

BIEL Stock  USD 0.0003  0.0001  50.00%   
About 51% of Bioelectronics Corp's institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Bioelectronics Corp pink sheet suggests that some investors are interested at this time. Bioelectronics Corp's investing sentiment shows overall attitude of investors towards Bioelectronics Corp.
Bioelectronics Corp pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bioelectronics daily returns and investor perception about the current price of Bioelectronics Corp as well as its diversification or hedging effects on your existing portfolios.
  
VENUS CONCEPT INC. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Bioelectronics Corp Fundamental Analysis

We analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Bioelectronics Corp is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Peers

Trending Equities

AA  3.33   
0%
100.0%
UPS  2.47   
0%
74.0%
INTC  2.41   
0%
72.0%
WFC  2.16   
0%
64.0%
HD  1.97   
0%
59.0%
AAPL  1.88   
0%
56.0%
MET  1.56   
0%
46.0%
AAL  1.44   
0%
43.0%
CVS  1.32   
0%
39.0%
CVX  1.20   
0%
36.0%
C  1.13   
0%
33.0%
TGT  0.81   
0%
24.0%
T  0.80   
0%
24.0%
S  0.45   
0%
13.0%
BBY  0.41   
0%
12.0%
IBM  0.25   
7.0%
0%

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.